The interaction between Myc and Miz1 is required to antagonize TGFbeta-dependent autocrine signaling during lymphoma formation and maintenance.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Genes & Development

• Publication date

  2010-06-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1101/gad.585710PMID 20551174PMCID PMC2885663
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor stroma-derived TGF-beta limits myc-driven lymphomagenesis via Suv39h1-dependent senescence.

  2010cited by this paper
• Cdk2 suppresses cellular senescence induced by the c-myc oncogene

  2010cited by this paper
• The Arf tumor suppressor protein inhibits Miz1 to suppress cell adhesion and induce apoptosis

  2010cited by this paper
• TGF-beta enforces senescence in Myc-transformed hematopoietic tumor cells through induction of Mad1 and repression of Myc activity.

  2009cited by this paper
• Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation

  2009cited by this paper
• Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor

  2008cited by this paper
• Max-independent functions of Myc in Drosophila melanogaster

  2008cited by this paper
• Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network.

  2008cited by this paper
• Myc's broad reach.

  2008cited by this paper
• Cellular senescence in vivo: a barrier to tumorigenesis.

  2008cited by this paper
• TGFbeta in Cancer.

  2008cited by this paper
• Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency

  2008cited by this paper
• Oncogene addiction versus oncogene amnesia: perhaps more than just a bad habit?

  2008cited by this paper
• Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas

  2007cited by this paper
• Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation

  2007influential reference
• Targeting of Miz-1 Is Essential for Myc-mediated Apoptosis*

  2006cited by this paper
• Myc regulates keratinocyte adhesion and differentiation via complex formation with Miz1

  2006cited by this paper
• Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication

  2006cited by this paper
• c-Myc phosphorylation is required for cellular response to oxidative stress.

  2006cited by this paper
• Skin epidermis lacking the c-Myc gene is resistant to Ras-driven tumorigenesis but can reacquire sensitivity upon additional loss of the p21Cip1 gene.

  2006cited by this paper
• N-Myc and the cyclin-dependent kinase inhibitors p18Ink4c and p27Kip1 coordinately regulate cerebellar development.

  2006cited by this paper
• Oncogene-induced senescence as an initial barrier in lymphoma development

  2005cited by this paper
• TGF-β directly targets cytotoxic T cell functions during tumor evasion of immune surveillance

  2005cited by this paper
• Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation.

  2005cited by this paper
• Tumour biology: Senescence in premalignant tumours

  2005cited by this paper
• MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer

  2004cited by this paper
• Developmental Context Determines Latency of MYC-Induced Tumorigenesis

  2004cited by this paper
• Miz1 Is Required for Early Embryonic Development during Gastrulation

  2003cited by this paper
• Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence.

  2003cited by this paper
• Negative regulation of the mammalian UV response by Myc through association with Miz-1.

  2002cited by this paper
• Suppression of Myc-Induced Apoptosis in β Cells Exposes Multiple Oncogenic Properties of Myc and Triggers Carcinogenic Progression

  2002cited by this paper
• N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation.

  2002cited by this paper
• Addiction to Oncogenes--the Achilles Heal of Cancer

  2002cited by this paper
• The myc oncogene: MarvelouslY Complex.

  2002cited by this paper
• Repression of p15INK4b expression by Myc through association with Miz-1

  2001cited by this paper
• c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations

  2001cited by this paper
• TGFβ influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b

  2001cited by this paper
• Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3

  2001cited by this paper
• Cellular Response to Oncogenic Ras Involves Induction of the Cdk4 and Cdk6 Inhibitor p15INK4b

  2000cited by this paper
• Reversible tumorigenesis by MYC in hematopoietic lineages.

  1999cited by this paper
• Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.

  1997cited by this paper
• Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame

  1997cited by this paper
• Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF.

  1997cited by this paper
• DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2.

  1997cited by this paper
• The absence of p21Cip1/WAF1 alters keratinocyte growth and differentiation and promotes ras-tumor progression.

  1996cited by this paper
• p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.

  1994cited by this paper
• The cdc25 protein controls tyrosine dephosphorylation of the cdc2 protein in a cell-free system.

  1991cited by this paper
• Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.

  1984cited by this paper

• The intervention of B. longum metabolites in Fnevs' carcinogenic capacity: A potential double-edged sword.

  2025cites this paper
• MYC controls STING levels to downregulate inflammatory signaling in breast cancer cells upon DNA damage

  2025cites this paper
• The Functions and Regulatory Chemicals of Human Leucine Zipper Transcription Factors (LZ TFs)

  2025cites this paper
• AlphaFold‐Guided Discovery of an Overlapping MYC/Miz‐1 Interface Enables Peptidomimetic Disruption of MYC/MAX

  2025cites this paper
• Macrophage regulation of tumor cell dormancy and the dormant niche: an overview in solid tumors

  2025cites this paper
• Targeting MYC at the intersection between cancer metabolism and oncoimmunology

  2024cites this paper
• MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer

  2024cites this paper
• Exploring Myc puzzle: Insights into cancer, stem cell biology, and PPI networks.

  2024cites this paper
• Immune evasion: An imperative and consequence of MYC deregulation

  2024cites this paper
• MYC-driven synthesis of Siglec ligands is a glycoimmune checkpoint

  2023cites this paper
• MYC Oncogene: A Druggable Target for Treating Cancers with Natural Products

  2023cites this paper
• MYC in liver cancer: mechanisms and targeted therapy opportunities

  2023cites this paper
• MYC multimers shield stalled replication forks from RNA polymerase

  2022cites this paper
• Lessons from Using Genetically Engineered Mouse Models of MYC-Induced Lymphoma

  2022cites this paper
• Normal and Neoplastic Growth Suppression by the Extended Myc Network

  2022cites this paper
• MYC promotes immune-suppression in triple-negative breast cancer via inhibition of interferon signaling

  2022cites this paper
• Autocrine TGF-β in Cancer: Review of the Literature and Caveats in Experimental Analysis

  2021cites this paper
• Autophagy and senescence: Insights from normal and cancer stem cells.

  2021cites this paper
• MXD/MIZ1 transcription regulatory complexes activate the expression of MYC‐repressed genes

  2021cites this paper
• Zinc Fingers 10 and 11 of Miz-1 undergo conformational exchange to achieve specific DNA binding.

  2021cites this paper
• Methods to Study Myc-Regulated Cellular Senescence: An Update.

  2021cites this paper
• The MYC oncogene — the grand orchestrator of cancer growth and immune evasion

  2021cites this paper
• The zinc finger protein Miz1 suppresses liver tumorigenesis by restricting hepatocyte-driven macrophage activation and inflammation.

  2021cites this paper
• Restriction of memory B cell differentiation at the germinal center B cell positive selection stage

  2020cites this paper
• Targeting MYC Proteins for Tumor Therapy

  2020cites this paper
• Pharmacological inactivation of CDK2 inhibits MYC/BCL-XL-driven leukemia in vivo through induction of cellular senescence

  2020cites this paper
• Myc-Miz-1 signaling promotes self-renewal of leukemia stem cells by repressing Cebpα and Cebpδ.

  2020cites this paper
• Target gene-independent functions of MYC oncoproteins

  2020cites this paper
• FGFR1 is associated with c‐MYC and proangiogenic molecules in metastatic renal cell carcinoma under anti‐angiogenic therapy

  2020cites this paper
• MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL

  2019cites this paper
• Deletion of the Miz-1 POZ domain increases efficacy of cytarabine treatment in T- and B-ALL/lymphoma mouse models.

  2019cites this paper
• MYC Recruits SPT5 to RNA Polymerase II to Promote Processive Transcription Elongation

  2019cites this paper
• MXD/MIZ1 complexes activate transcription of MYC-repressed genes

  2019cites this paper
• MYC in Germinal Center‐derived lymphomas: Mechanisms and therapeutic opportunities

  2019cites this paper
• Dormancy and cancer stem cells: An enigma for cancer therapeutic targeting.

  2019cites this paper
• The dynamic nature of senescence in cancer

  2019cites this paper
• Interaction of the oncoprotein transcription factor MYC with its chromatin cofactor WDR5 is essential for tumor maintenance

  2019cites this paper
• Targeting the MYC Oncogene in Burkitt Lymphoma through HSP90 Inhibition

  2018cites this paper
• MYC—Master Regulator of the Cancer Epigenome and Transcriptome

  2017cites this paper
• In Utero Exposure to a High‐Fat Diet Programs Hepatic Hypermethylation and Gene Dysregulation and Development of Metabolic Syndrome in Male Mice

  2017cites this paper
• Differential cellular responses by oncogenic levels of c-Myc expression in long-term confluent retinal pigment epithelial cells

  2017cites this paper
• DNMT3B overexpression contributes to aberrant DNA methylation and MYC-driven tumor maintenance in T-ALL and Burkitt’s lymphoma

  2017influential citation
• OmoMYC blunts promoter invasion by oncogenic MYC to inhibit gene expression characteristic of MYC-dependent tumors

  2017cites this paper
• c-Myc Antagonises the Transcriptional Activity of the Androgen Receptor in Prostate Cancer Affecting Key Gene Networks

  2017cites this paper
• Miz-1 promotes the proliferation of esophageal cancer cells via suppression of p21 and release of p21-arrested cyclin D1.

  2016cites this paper
• MYC/MIZ1-dependent gene repression inversely coordinates the circadian clock with cell cycle and proliferation

  2016cites this paper
• Identification of MYC-Dependent Transcriptional Programs in Oncogene-Addicted Liver Tumors.

  2016influential citation
• The Interaction of Myc with Miz1 Defines Medulloblastoma Subgroup Identity.

  2016cites this paper
• Different promoter affinities account for specificity in MYC-dependent gene regulation

  2016cites this paper
• MYC in pancreatic cancer: novel mechanistic insights and their translation into therapeutic strategies

  2016cites this paper
• Pin1 is required for sustained B cell proliferation upon oncogenic activation of Myc

  2016cites this paper
• Structural Insights into c-Myc-interacting Zinc Finger Protein-1 (Miz-1) Delineate Domains Required for DNA Scanning and Sequence-specific Binding*

  2016cites this paper
• MYC and Chromatin

  2015cites this paper
• Convergence of cMyc and β‐catenin on Tcf7l1 enables endoderm specification

  2015cites this paper
• Taming of the beast: shaping Myc-dependent amplification.

  2015cites this paper
• MYC: connecting selective transcriptional control to global RNA production

  2015cites this paper
• BTB-ZF Protein Znf131 Regulates Cell Growth of Developing and Mature T Cells

  2015cites this paper
• Repression of SRF target genes is critical for Myc‐dependent apoptosis of epithelial cells

  2015cites this paper
• MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolism

  2015cites this paper
• ARF: Connecting senescence and innate immunity for clearance

  2015cites this paper
• Cystathionase mediates senescence evasion in melanocytes and melanoma cells

  2014cites this paper
• Late Onset Neuropathy with Spontaneous Clinical Remission in Mice Lacking the POZ Domain of the Transcription Factor Myc-interacting Zinc Finger Protein 1 (Miz1) in Schwann Cells*

  2014cites this paper
• Inactivation of MYC reverses tumorigenesis

  2014cites this paper
• Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles

  2014cites this paper
• MYC activation is a hallmark of cancer initiation and maintenance.

  2014cites this paper
• BTB‐ZF transcription factors, a growing family of regulators of early and late B‐cell development

  2014cites this paper
• Genome recognition by MYC.

  2014cites this paper
• Pancreatic Dysfunction in Shwachman-Diamond Syndrome

  2014cites this paper
• Miz1 Deficiency in the Mammary Gland Causes a Lactation Defect by Attenuated Stat5 Expression and Phosphorylation

  2014cites this paper
• Structures of heterodimeric POZ domains of Miz1/BCL6 and Miz1/NAC1.

  2014cites this paper
• Nac1 interacts with the POZ-domain transcription factor, Miz1

  2014cites this paper
• Mammalian MYC Proteins and Cancer

  2014cites this paper
• Function of the Myc-binding protein Miz1 in the mouse mammary gland

  2014cites this paper
• Interplay between the myc oncoprotein, cyclin-dependent kinases and e3 ubiquitin ligases

  2013cites this paper
• Miz1 is required to maintain autophagic flux

  2013cites this paper
• Unlocking the mysterious mechanisms of Myc

  2013cites this paper
• The mTORC1 inhibitor everolimus prevents and treats Eμ-Myc lymphoma by restoring oncogene-induced senescence.

  2013cites this paper
• Methods to study MYC-regulated cellular senescence.

  2013cites this paper
• The role of MIZ-1 in MYC-dependent tumorigenesis.

  2013cites this paper
• Noncanonical roles of the immune system in eliciting oncogene addiction.

  2013cites this paper
• Tumor dormancy, oncogene addiction, cellular senescence, and self-renewal programs.

  2013cites this paper
• A Canonical Transforming Growth Factor Beta-Dependent Signaling Pathway is Present in Peripheral Blood Cells of Cancer Patients with Skeletal Metastasis

  2013cites this paper
• Transcription regulation network analysis of MCF7 breast cancer cells exposed to estradiol.

  2012cites this paper
• POK/ZBTB proteins: an emerging family of proteins that regulate lymphoid development and function

  2012cites this paper
• Immunology in the clinic review series; focus on cancer: multiple roles for the immune system in oncogene addiction

  2012cites this paper
• Miz1 Is a Critical Repressor of cdkn1a during Skin Tumorigenesis

  2012cites this paper
• “Picolog,” a Synthetically-Available Bryostatin Analog, Inhibits Growth of MYC-Induced Lymphoma In Vivo

  2012cites this paper
• Senescence: a new weapon for cancer therapy.

  2012cites this paper
• The BTB/POZ Transcription Factor Miz-1 Is Required To Regulate The Commitment, Survival And Differentiation Of Early B And T Cell Lineages

  2012cites this paper
• Suppression of Myc oncogenic activity by nucleostemin haploinsufficiency

  2012cites this paper
• MYC on the path to cancer.

  2012cites this paper
• Pten mediates Myc oncogene dependence in a conditional zebrafish model of T cell acute lymphoblastic leukemia

  2011cites this paper
• Antagonistic TSC22D1 variants control BRAFE600‐induced senescence

  2011cites this paper
• Interrogating Resistance to Targeted Therapy Using Genetically Engineered Mouse Models of Cancer

  2011cites this paper
• Lymphomas that recur after MYC suppression continue to exhibit oncogene addiction

  2011cites this paper
• RB1 and p53 at the crossroad of EMT and triple-negative breast cancer

  2011cites this paper
• The role of the transcription factor Miz-1 in lymphocyte development and lymphomagenesis-Binding Myc makes the difference.

  2011cites this paper
• Oncogene- and tumor suppressor gene-mediated suppression of cellular senescence.

  2011cites this paper
• Transcriptional Suppression of Sertoli Cell Timp2 in Rodents Following Mono-(2-ethylhexyl) Phthalate Exposure Is Regulated by CEBPA and MYC1

  2011cites this paper
• Analysis of secretome changes uncovers an autocrine/paracrine component in the modulation of cell proliferation and motility by c-Myc.

  2011cites this paper